Test your knowledge on adverse event monitoring in mTNBC

Patients taking carboplatin are at high risk for CINV.
True
False
On which of the following side effects would you counsel a patient with mTNBC being treated with olaparib?
Skin rash, fatigue, cough
Palpitations, nausea, headache
Diarrhea, skin rash, cough
Anemia, fatigue, nausea
How can most immune-related adverse events be managed for patients with mTNBC who are treated with pembrolizumab?
Blood transfusion
Antiemetics
Steroids
Immuno-modulating therapy
Which of the following therapies would you administer prior to infusion with sacituzumab govitecan?
Antibiotic, antiemetic, H2 blocker
Antiemetic, H2 blocker, steroid
Combination antiemetics, antipyretic, H2 blocker
Single-agent antiemetic, antibiotic, antipyretic
0
{"name":"Test your knowledge on adverse event monitoring in mTNBC", "url":"https://www.quiz-maker.com/Q7MS65H3E","txt":"Patients taking carboplatin are at high risk for CINV., On which of the following side effects would you counsel a patient with mTNBC being treated with olaparib?, How can most immune-related adverse events be managed for patients with mTNBC who are treated with pembrolizumab?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys